Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCYTOMX THERAPEUTICS INC - Capital Expenditures Coverage Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTMX - CapEx Coverage Historical data
| Date | Capital Expenditure | Capital Expenditures Coverage | Net Cash Flow - Operations |
|---|---|---|---|
| 6/30/2025 | $ 245K | 0 | $ -77.43M |
| 3/31/2025 | $ 314K | 0 | $ -81.23M |
| 12/31/2024 | $ 310K | 0 | $ -86.23M |
| 9/30/2024 | $ 496K | 0 | $ -88.29M |
| 6/30/2024 | $ 486K | 0 | $ -85.8M |
| 3/31/2024 | $ 907K | 0 | $ -91.43M |
| 12/31/2023 | $ 840K | 0 | $ -56.03M |
| 9/30/2023 | $ 756K | 0 | $ -35.47M |
| 6/30/2023 | $ 1.16M | 0 | $ -51.07M |
| 3/31/2023 | $ 1.05M | 0 | $ -60.13M |
Key Performance Insights, Last 5 Years
- CYTOMX THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx Coverage stands at 0.
- Over the past 5 years, CYTOMX THERAPEUTICS INC's average CapEx Coverage has been 6.73.
- The median CapEx Coverage for CYTOMX THERAPEUTICS INC during this period was 6.73
- CYTOMX THERAPEUTICS INC reached its highest CapEx Coverage over the past 5 years at 11.18.
- The lowest CapEx Coverage recorded by CYTOMX THERAPEUTICS INC in the same timeframe 2.28
CYTOMX THERAPEUTICS INC's CapEx Coverage vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx Coverage Benchmarks
Similar metrics to CF - Operations:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
Definition of Capital Expenditures Coverage
[Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].CF - Operations / CapEx
(=) CapEx Coverage CapEx Coverage for CYTOMX THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -6.79M ] / CapEx [ $ 2.57M ]
(=) CapEx Coverage [ 0 ] CTMX - Capital Expenditures Coverage, Last 5 years
2.28
Minimum
Dec 31, 2020
11.18
Maximum
Mar 31, 2021
6.73
Average
6.73
Median
CapEx Coverage Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx Coverage for companies in the Total Stock Market. The average CapEx Coverage of the companies is 4.42 with a standard deviation of 4.02.
The following table provides additional summary stats:
CapEx Coverage in the Market:
| filtered constituents | 2.21K |
|---|---|
| min | 0.01 |
| max | 17.91 |
| average | 4.42 |
| median | 3.01 |
| std | 4.02 |